Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools GIST

GIST

Programs, trials, and reported response and survival for gastrointestinal stromal tumor.

Data as of 11.07.2026

All studies

Regorafenib

GRID

Bayer · Phase 3 · Completed · Enrollment 199

NCT01271712

ArmReported safety
Regorafenib 160 mg, 3 weeks on 1 offn/r
Placebon/r

A count stays a count. This page does not turn a count into a percent.